drugset / Trial / NCT01017159
Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2
Completed
30 enrolled
University of Aarhus
Baxter Healthcare Corporation · collabGCP-unit at Aarhus University Hospital, Aarhus, Denmark · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether subcutaneous immunoglobulin given in small doses, is effective in maintaining the force, in patients with chronic inflammatory demyelinating polyradiculoneuropathy compared with placebo (saline infusions), and intravenous immunoglobulin.
Timeline
- Start
- 2010-04
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Subcutaneous immunoglobulin | Protein / enzyme biologic | 20 ml | Subcutaneous |